Dr Ash Wechalekar, Consultant Haematologist
Dr Ash Wechalekar
Consultant Haematologist
Dr Ash Wechalekar MB BS, MD, FRCP, FRCPath, DM
Consultant Haematologist
Dr Ash Wechalekar
Consultant Haematologist MB BS, MD, FRCP, FRCPath, DM
About Dr Ash Wechalekar
GMC number: 5191273
Year qualified: 1992
Place of primary qualification: Nagpur University
Areas of expertise
- Myeloma
- Amylodoisis
- Waldenstrom’s macroglobulinaemia
- Plasma cell dyscrasia
- Renal disease
Professional memberships
Articles by Dr Ash Wechalekar
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of national amyloidosis centre transthyretin amyloidosis stage
Eight novel loci implicate shared genetic etiology in multiple myeloma, al amyloidosis, and monoclonal gammopathy of unknown significance
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in al amyloidosis
Preclinical toxicology and safety pharmacology of the first-in-class gadd45β/mkk7 inhibitor and clinical candidate, dtp3
Outcomes of 44 patients with newly diagnosed systemic light-chain amyloidosis associated with deletion 17p
Extracardiac 18f-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds